PD-1 expression on tumor cells: a new target for cancer therapy

Transl Lung Cancer Res. 2024 Jan 31;13(1):186-189. doi: 10.21037/tlcr-23-683. Epub 2024 Jan 25.

Authors

Mari Tone^{1

2}, Kota Iwahori^{1

2}

Affiliations

¹ Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
² Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.

No abstract available

Keywords: Anti programmed death-1 antibody (anti-PD-1 antibody); cancer stemness; chemoresistance; non-small cell lung cancer (NSCLC).

Publication types

Editorial
Comment